Form 4 for EVMN Evommune, Inc.
Accepted 2025-12-22 00:00:00 ET · period of report 2025-12-19 · accession 0001012975-25-000937 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-12-22 | 2025-12-19 | EVMN | Hopfner Robert Lorne | Dir, 10% | P - Purchase | $17.35 | +1,000 | 4,026 | +33% | +$17.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-19 | P | A | 1,000 | $17.35 | 4,026 | I By Trust | — | — | (F1) The securities are held by a family trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein. |